# Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis

> **NCT04815785** · NA · UNKNOWN · sponsor: **Peijia Medical Technology (Suzhou) Co., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DEVICE:** TaurusOne® transcatheter aortic valve replacement system

## Key facts

- **NCT ID:** NCT04815785
- **Lead sponsor:** Peijia Medical Technology (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-22
- **Primary completion:** 2020-05-11
- **Final completion:** 2024-05-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-10-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04815785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04815785, "Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04815785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*